Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.

Albrethsen J, Knol JC, Piersma SR, Pham TV, de Wit M, Mongera S, Carvalho B, Verheul HM, Fijneman RJ, Meijer GA, Jimenez CR.

Mol Cell Proteomics. 2010 May;9(5):988-1005. doi: 10.1074/mcp.M900546-MCP200. Epub 2010 Jan 20.

2.

Proteomics of differential extraction fractions enriched for chromatin-binding proteins from colon adenoma and carcinoma tissues.

Knol JC, de Wit M, Albrethsen J, Piersma SR, Pham TV, Mongera S, Carvalho B, Fijneman RJ, Meijer GA, Jiménez CR.

Biochim Biophys Acta. 2014 May;1844(5):1034-43. doi: 10.1016/j.bbapap.2013.12.006. Epub 2013 Dec 17.

PMID:
24361553
3.

Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.

de Wit M, Jimenez CR, Carvalho B, Belien JA, Delis-van Diemen PM, Mongera S, Piersma SR, Vikas M, Navani S, Pontén F, Meijer GA, Fijneman RJ.

Gut. 2012 Jun;61(6):855-64. doi: 10.1136/gutjnl-2011-300511. Epub 2011 Sep 2.

PMID:
21890811
4.

A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.

Besson D, Pavageau AH, Valo I, Bourreau A, Bélanger A, Eymerit-Morin C, Moulière A, Chassevent A, Boisdron-Celle M, Morel A, Solassol J, Campone M, Gamelin E, Barré B, Coqueret O, Guette C.

Mol Cell Proteomics. 2011 Dec;10(12):M111.009712. doi: 10.1074/mcp.M111.009712. Epub 2011 Oct 10.

5.

Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology.

Chen D, Chen F, Lu X, Yang X, Xu Z, Pan J, Huang Y, Lin H, Chi P.

Int J Oncol. 2010 Aug;37(2):355-65.

PMID:
20596663
6.

Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.

Alfonso P, Núñez A, Madoz-Gurpide J, Lombardia L, Sánchez L, Casal JI.

Proteomics. 2005 Jul;5(10):2602-11.

PMID:
15924290
7.

Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.

Milone MR, Pucci B, Colangelo T, Lombardi R, Iannelli F, Colantuoni V, Sabatino L, Budillon A.

Mol Oncol. 2016 Oct;10(8):1344-62. doi: 10.1016/j.molonc.2016.07.006. Epub 2016 Jul 25.

8.

Identification of distinctive protein expression patterns in colorectal adenoma.

F Lam F, Jankova L, Dent OF, Molloy MP, Kwun SY, Clarke C, Chapuis P, Robertson G, Beale P, Clarke S, Bokey EL, Chan C.

Proteomics Clin Appl. 2010 Jan;4(1):60-70. doi: 10.1002/prca.200900084. Epub 2009 Nov 3.

PMID:
21137016
9.

Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis.

Liu W, Ma Y, Huang L, Peng J, Zhang P, Zhang H, Chen J, Qin H.

Mol Biol Rep. 2010 Oct;37(7):3207-16. doi: 10.1007/s11033-009-9903-x. Epub 2009 Oct 16.

PMID:
19842058
10.

Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.

Zhang J, Song MQ, Zhu JS, Zhou Z, Xu ZP, Chen WX, Chen NW.

Int J Immunopathol Pharmacol. 2011 Oct-Dec;24(4):849-59.

PMID:
22230392
11.

Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study.

Uzozie A, Nanni P, Staiano T, Grossmann J, Barkow-Oesterreicher S, Shay JW, Tiwari A, Buffoli F, Laczko E, Marra G.

Mol Cell Proteomics. 2014 May;13(5):1198-218. doi: 10.1074/mcp.M113.035105. Epub 2014 Feb 24.

12.

The nuclear matrix shell proteome of human epidermis.

Warters RL, Cassidy PB, Sunseri JA, Parsawar K, Zhuplatov SB, Kramer GF, Leachman SA.

J Dermatol Sci. 2010 May;58(2):113-22. doi: 10.1016/j.jdermsci.2010.03.001. Epub 2010 Mar 6.

PMID:
20363599
13.

Profiling of differentially expressed proteins in stage IV colorectal cancers with good and poor outcomes.

Kim HJ, Kang UB, Lee H, Jung JH, Lee ST, Yu MH, Kim H, Lee C.

J Proteomics. 2012 Jun 6;75(10):2983-97. doi: 10.1016/j.jprot.2011.12.002. Epub 2011 Dec 10.

PMID:
22178445
14.

Mapping the Spatial Proteome of Metastatic Cells in Colorectal Cancer.

Mendes M, Peláez-García A, López-Lucendo M, Bartolomé RA, Calviño E, Barderas R, Casal JI.

Proteomics. 2017 Oct;17(19). doi: 10.1002/pmic.201700094.

PMID:
28861940
15.

Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.

Wang CI, Chien KY, Wang CL, Liu HP, Cheng CC, Chang YS, Yu JS, Yu CJ.

Mol Cell Proteomics. 2012 Nov;11(11):1105-22. doi: 10.1074/mcp.M111.016592. Epub 2012 Jul 25.

16.

Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry.

Kang UB, Yeom J, Kim HJ, Kim H, Lee C.

J Proteomics. 2012 Jun 6;75(10):3050-62. doi: 10.1016/j.jprot.2011.11.021. Epub 2011 Nov 26.

PMID:
22154799
17.

Immunoscreening of the extracellular proteome of colorectal cancer cells.

Klein-Scory S, Kübler S, Diehl H, Eilert-Micus C, Reinacher-Schick A, Stühler K, Warscheid B, Meyer HE, Schmiegel W, Schwarte-Waldhoff I.

BMC Cancer. 2010 Feb 25;10:70. doi: 10.1186/1471-2407-10-70.

18.

Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.

Kim H, Kang HJ, You KT, Kim SH, Lee KY, Kim TI, Kim C, Song SY, Kim HJ, Lee C, Kim H.

Proteomics. 2006 Jun;6(11):3466-76.

PMID:
16645984
19.

Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.

Carvalho B, Sillars-Hardebol AH, Postma C, Mongera S, Terhaar Sive Droste J, Obulkasim A, van de Wiel M, van Criekinge W, Ylstra B, Fijneman RJ, Meijer GA.

Cell Oncol (Dordr). 2012 Feb;35(1):53-63. doi: 10.1007/s13402-011-0065-1. Epub 2012 Jan 26.

20.

The roles of JK-1 (FAM134B) expressions in colorectal cancer.

Kasem K, Gopalan V, Salajegheh A, Lu CT, Smith RA, Lam AK.

Exp Cell Res. 2014 Aug 1;326(1):166-73. doi: 10.1016/j.yexcr.2014.06.013. Epub 2014 Jun 25.

PMID:
24973512

Supplemental Content

Support Center